Last updated: 5 June 2024 at 4:12pm EST

Ourania Tatsis Net Worth




The estimated Net Worth of Ourania Tatsis is at least $32.4 Milion dollars as of 3 June 2024. Ourania Tatsis owns over 2,175 units of Vertex Pharmaceuticals stock worth over $23,308,785 and over the last 5 years Ourania sold VRTX stock worth over $9,111,810.

Ourania Tatsis VRTX stock SEC Form 4 insiders trading

Ourania has made over 26 trades of the Vertex Pharmaceuticals stock since 2019, according to the Form 4 filled with the SEC. Most recently Ourania sold 2,175 units of VRTX stock worth $1,000,500 on 3 June 2024.

The largest trade Ourania's ever made was selling 5,750 units of Vertex Pharmaceuticals stock on 10 August 2023 worth over $1,988,293. On average, Ourania trades about 1,004 units every 52 days since 2019. As of 3 June 2024 Ourania still owns at least 49,098 units of Vertex Pharmaceuticals stock.

You can see the complete history of Ourania Tatsis stock trades at the bottom of the page.



What's Ourania Tatsis's mailing address?

Ourania's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON, MA, 02210.

Insiders trading at Vertex Pharmaceuticals

Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden a Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.



What does Vertex Pharmaceuticals do?

Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.



Complete history of Ourania Tatsis stock trades at Vertex Pharmaceuticals

Osoba
Trans.
Transakce
Celková cena
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $1,000,500
3 Jun 2024
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $2,033,154
30 May 2024
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $150,698
23 Feb 2024
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $151,837
21 Feb 2024
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $201,979
16 Feb 2024
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $131,955
9 Feb 2024
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $887,500
23 Aug 2023
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $1,988,293
10 Aug 2023
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $101,768
24 Feb 2023
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $141,000
17 Feb 2023
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $95,526
14 Feb 2023
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $82,222
10 Feb 2023
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $418,558
9 Aug 2022
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $708,562
17 Mar 2022
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $75,059
24 Feb 2022
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $119,889
17 Feb 2022
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $68,176
10 Feb 2022
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $34,080
15 May 2020
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Využití opce $168,142
6 May 2020
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $302,188
24 Feb 2020
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $311,590
17 Feb 2020
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Využití opce $168,306
5 Feb 2020
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Využití opce $314,113
8 Jan 2020
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $1,030
15 Nov 2019
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Využití opce $443,841
13 Nov 2019
Ourania Tatsis
EVP, Chief Reg. a Quality Off.
Prodej $106,246
1 Oct 2019


Vertex Pharmaceuticals executives and stock owners

Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: